Sort
85,873 grants matching “alzheimers”
Elevated FSH - A Driver for Sex Differences in Alzheimer's Disease
$1,242,150Mone Zaidi · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · AG
ALZHEIMER'S DISEASE CORE CENTER
$1,242,135William R Markesbery · University Of Kentucky · P30 · FY2008 · AG
Discovery of Novel Drugs for Alzheimer's Disease
$1,241,780James W. Simpkins · University Of North Texas Hlth Sci Ctr · P01 · FY2007 · AG
NEURONAL &VASCULAR PATHOBIOLOGY IN ALZHEIMER'S DISEASE
$1,241,767Nathan S. Kline Institute For Psych Res · P01 · FY2003 · AG
Core B: Clinical Core
$1,241,732Constantine G Lyketsos · Johns Hopkins University · P30 · FY2023 · AG
An acoustofluidic device for diagnosing preclinical Alzheimer's disease
$1,241,166Lin Wang · Ascent Bio-Nano Technologies, Inc. · R44 · FY2022 · AG
Oregon Alzheimer's Disease Center
$1,240,828Jeffrey A Kaye · Oregon Health & Science University · P30 · FY2012 · AG
Behavioral Shifts in Dementia Patients Using Novel Pharmacy Home Robotics: A Cost-Effective Approach to Aging in Place
$1,240,765Charles Gellman · Hido Technologies, Inc. · R44 · FY2025 · AG
Structure-based discovery of allosteric ligands for G Protein Coupled Receptors
$1,240,674Brian K Kobilka · Stanford University · U19 · FY2014 · GM
An acoustofluidic device for diagnosing preclinical Alzheimer's disease
$1,240,614Lin Wang · Ascent Bio-Nano Technologies, Inc. · R44 · FY2021 · AG
Impact of sex differences on the trajectory of interactome dysfunctions across the AD spectrum
$1,240,570Gabriela Chiosis · Sloan-Kettering Inst Can Research · R01 · FY2021 · AG
Device to control circadian-effective light in Alzheimer's disease environments
$1,240,470Erik Page · Erik Page And Associates, Inc. · R44 · FY2019 · AG
Neuroinflammatory mechanisms underlying sepsis-induced cognitive dysfunction
$1,240,442Fiona Edith Harrison · Vanderbilt University Medical Center · RF1 · FY2025 · AG
Protective factors and mechanisms
$1,240,439Doo Yeon Kim · Boston University Medical Campus · U19 · FY2021 · AG
Growth Hormone & IGF-1 in CNS and Cerebrovascular Aging
$1,240,365William Edmund Sonntag · University Of Oklahoma Hlth Sciences Ctr · P01 · FY2010 · AG
TAU AND NEURODEGENERATION
$1,240,362Mayo Clinic Coll Of Medicine, Rochester · P01 · FY2001 · AG
Roles of Gray Matter Brain Aging and Small Vessel Disease in AD Pathophysiology
$1,240,339Howard J Aizenstein · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · AG
Mechanisms of Aging in the Olfactory System
$1,240,263Charles A Greer · Yale University · P01 · FY2007 · AG
1 of 5 ARIC Neurocognitive Study (ARIC-NCS)
$1,240,198Josef Coresh · Johns Hopkins University · U01 · FY2010 · HL
Impact of Depression on Alzheimer's disease: Prenatal Immune Origins and Shared Impact of Sex
$1,240,167Jill M Goldstein · Massachusetts General Hospital · R01 · FY2023 · AG
Clinical Core
$1,240,056Beth Snitz · University Of Pittsburgh At Pittsburgh · P01 · FY2023 · AG
Small molecule targeting an epigenetic regulator for the treatment of osteoarthritis
$1,239,916Maddalena Adorno · Dorian Therapeutics, Inc. · U44 · FY2022 · AG
Clinical Core
$1,239,814Cynthia M Carlsson · University Of Wisconsin-Madison · P30 · FY2021 · AG
A Diagnostic Test for Dementia with Lewy Bodies
$1,239,804Todd Levine · Cnd Life Sciences, Inc. · R44 · FY2022 · AG
Structure-based discovery of allosteric ligands for G Protein Coupled Receptors
$1,239,747Brian K Kobilka · Stanford University · U19 · FY2015 · GM